TABLE 1.

Demographics and clinical characteristics of patients with COVID‐19 ARDS and non‐COVID‐19 ARDS

Patient code	Respiratory infection	Age	Sex	Comorbidities	Intubated (days)
ARDS‐201	Aspiration pneumonia	74	F	CAD, DM2, HTN, breast cancer, dementia	25
ARDS‐3	Bacterial pneumonia	77	M	CAD, DM1, PE, dementia	None
ARDS‐4	Bacterial pneumonia	39	F	Sjogren’s syndrome	3
ARDS‐5	Bacterial pneumonia	34	M	CAD, gastric cancer	15
ARDS‐203	Bacterial pneumonia, Influenza	47	F	DM2, HTN, hypothyroidism	4
COVID‐10	SARS‐CoV‐2 pneumonia	56	F	DM2, HTN, sickle cell anemia	None
COVID‐11	SARS‐CoV_2 pneumonia	75	M	HTN, lung cancer	25
COVID‐14	SARS‐CoV‐2 pneumonia	70	M	Arteritis	None
COVID‐19	SARS‐CoV‐2 pneumonia	70	M	Unknown	None
COVID‐20	SARS‐CoV‐2 pneumonia	30	F	Diabetes, pulmonary valve atresia	12
COVID‐30	SARS‐CoV‐2 pneumonia	52	M	CAD, HDK, DM2	29
COVID‐7	SARS‐CoV‐2 pneumonia	69	M	DM2, AML	None
COVID‐2	SARS‐CoV‐2 pneumonia	73	M	Pre‐diabetes, COPD	5
COVID‐3	SARS‐CoV‐2 pneumonia	71	M	Diabetes, HTN	None
COVID‐8	SARS‐CoV‐2 pneumonia	46	M	DM2, HTN, asthma	7
COVID‐OK	SARS‐CoV‐2 Pneumonia, cardiac arrest	77	M	HTN, splenectomy	None

Abbreviations: AML, acute myelogenous leukemia; ARDS, acute respiratory distress syndrome; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; COVID, coronavirus disease; DM1, type 1 diabetes mellitus; DM2, type 2 diabetes mellitus; HLD, hyperlipidemia; HTN, hypertension; PE, pulmonary embolism; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.